In the quarter, it lost almost $55 million, or $2.07 per share. On March 23, Cassava Sciences, Inc. (NASDAQ: SAVA) posted earnings for the first quarter of 2021. In this leading edge volume, Professor Burns focuses on the key role of the 'producers' as the main source of innovation in health systems. Amarin has the attention of four Wall Street analysts. Well for starters, these stocks focus on biotechnology is the broad area of biology, involving living systems and organisms to develop or make products. Fellow Fool Brian Stoffel defines a millionaire-making stock as one that can return 10 times its value in 20 years. Getting an even larger dividend payment this year. It is the second-largest holding of the New York-based fund. On July 20, H.C. Wainwright analyst Vernon Bernardino raised the firm's price target on Cassava Sciences to $124 from $97 and kept a “Buy” rating. On Aug. 23, Theravance Biopharma posted results for its Phase 2b dose-finding induction study. That will change for the better when the companies bring an approved drug to the market. The company helps advance methodologies related to clinical studies on neurodegenerative diseases. Found insideWith her signature mix of insight, compassion, and practical advice, Suze equips women with the financial knowledge and emotional awareness to overcome the blocks that have kept them from acting in the best interest of their money—and ... But Arcturus had $433.6 million in cash as of June 30, 2021. Companies in the biotech (biotechnology) space manufacture drugs, therapies, … quotes delayed at least 15 minutes, all others at least 20 minutes. On May 10, Constellation Pharmaceuticals, Inc. (NASDAQ: CNST) posted earnings for the first quarter of 2021. It was founded in 2017 and is placed ninth on the list of 10 best pharma and biotech stocks to buy according to Jim Simons' Euclidean Capital. This drug is a maintenance treatment for patients suffering from chronic obstructive pulmonary disease. The Complete List of Biotech Stocks Trading on the NASDAQ as of Aug 22, 2021 are listed below: Note: If you are looking for Biotech Stocks trading on the NYSE click here. It was founded in 2016, and it ranks tenth on the list of 10 best pharma and biotech stocks to buy according to Jim Simons' Euclidean Capital. Biotech Stocks In BofA's Coverage Having Second-half Catalysts The following is the list of catalysts for biotech stocks covered by BofA Securities analyst Jason Gerberry: Biotechnology can be safe, but potential risks exist. The continued safe use of biotechnology requires constant vigilance on a case-by-case basis. Scientists are responsible for careful preparation of recombinant organisms involved in research or product development. 5 Best Pharma and Biotech Stocks to Buy According to Jim Simons' Euclidean Capital, 11 Best Pharma and Biotech Stocks to Buy According to Jim Simons' Euclidean Capital, U.S. families are unprepared for an unexpected death: USAA, Oil Advances With Ida’s Impact on U.S. Supply Lingering, Walmart Breaks Green Bond Record With $2 Billion Debut Issuance, MOVES-Goldman Sachs hires McKinsey partner as co-head of Asia region, Here’s why investors are selling Tesla and buying Ford, GM: Analyst, 3 Top Electric Vehicle Stocks to Buy for the Long Haul, 5 Stocks With 195% to 467% Upside, According to Wall Street, 3 Reasons to Buy AT&T, and 1 Reason To Sell, 2 Key Stocks Could Crush the Market's Hopes Wednesday, 8 Companies Already Paying Huge Dividends Just Hiked Them, Stanley Druckenmiller is Dumping These 10 Stocks, Dow Jones Slides As Yellen Warns Congress; Apple Sells Off From Record High; Tesla Skids Amid China Sales, Apple stock falls as investors look ahead to Apple iPhone 13 event. Shares of the digital advertising technology (ad-tech) company are up more than 4,000% from its (split-adjusted) IPO price of $1.80in 2016. 2.1 Biotech Stocks to Watch #1: ALX Oncology Holdings Inc. (NASDAQ: ALXO) 2.2 Biotech Stocks to Watch #2: Dynavax Technologies Corporation (NASDAQ: DVAX) 2.3 Biotech Stocks to Watch #3: Humanigen, Inc. (NASDAQ: HGEN) Bluebird said it does not expect the hold to have an impact on its sickle cell disease (SCD), β-thalassemia or oncology programs. The biotech industry is expanding because of the world’s need for a coronavirus vaccine. They also make diagnostic products. Biotechnology Stocks Biotech companies leverage cutting-edge science to create medicines and treatments for a multitude of diseases, making them high-risk, high-reward opportunities for investors looking to profit from healthcare innovation. Shares of Smartsheet (NYSE: SMAR), a provider of workflow automation software, had tumbled 10.6% by 9:40 a.m. EDT Wednesday despite reporting an earnings beat Tuesday night. Here's a roundup of top developments in the biotech space over the last 24 hours. As of 11:06 a.m. EDT, NIO's American depositary shares were down by about 6% from Tuesday's closing price. The historical mean forward P/E multiple is 16x from 1976 through March 2013 for pharma as compared to … is the biggest stakeholder in the company, with 67,963 shares worth $2.30 million. It reported earnings per share of -$0.84, missing market predictions by $0.05. Found inside – Page 155This was underscored last month when four biotechnology firms were able to go public after major drug and biotech ... Price Controls , Stock Prices and Pharmaceutical R & D The deteriorating capital position of bio - pharmaceutical ... In the second quarter, Quanterix posted record product revenue of $18.7 million, up 175% year-over-year. It was founded in 2015 and is ranked seventh on the list of 10 best pharma and biotech stocks to buy according to Jim Simons' Euclidean Capital. Enbridge (NYSE: ENB) recently made a big splash. … Vir Biotechnology, Inc. (NASDAQ: VIR) is the latest addition in Jim Simons' hedge fund portfolio, as Euclidean Capital bought 25,864 shares of the company, worth $1.33 million. Investors should appreciate the value that Cassava will bring to the treatment of Alzheimer’s disease. On the date of publication, Chris Lau did not have (either directly or indirectly) any positions in the securities mentioned in this article. He founded probably the most successful quantitative investment firm in the world, Renaissance Technologies, in 1982 and retired in 2010. Foghorn Therapeutics Inc. (NASDAQ: FHTX) is mainly in the business of pharmaceutical preparations. The hedge fund chaired by Jim Simons holds 735,801 shares in RAPT Therapeutics, Inc. (NASDAQ: RAPT) worth $16.34 million. AstraZeneca (NASDAQ:AZN) and Pfizer (NYSE:PFE) are established mega capitalization firms that also fared well for investors. Integrating the scientific, the corporate, the contextual, and the personal, Genentech tells the story of biotechnology as it is not often told, as a risky and improbable entrepreneurial venture that had to overcome a number of powerful ... In this article, we will discuss the 11 best pharma and biotech stocks to buy according to Jim Simons' Euclidean Capital. As it turned out, Smartsheet lost only $0.05 per share, and its sales beat expectations, rising 44% year over year to $131.7 million. Beam shares have gained about 339.99% in value over the last 12 months. The nebulized formulation, AT-H201, is being prepared as an inhalation therapy for critically ill COVID-19 patients. "Helps you understand one of the most discussed but least understood sectors of the knowledge economy." - preface. In 2020, for obvious reasons, there was a lot of attention on the pharmaceutical industry. On the other hand, companies like Annovis Bio, Inc. (NYSE: Annovis Bio, Inc. (NYSE: ANVS) is a clinical-stage drug platform company. On July 20, H.C. Wainwright analyst Vernon Bernardino raised the firm's price target on Cassava Sciences to $124 from $97 and kept a “Buy” rating. Its Covid-19 mRNA vaccine candidate is in Phase 3 in Vietnam, and the company may earn an Emergency Use Authorization (EUA) in December. 4 Top Biotech Stocks To Watch This MonthAs investors look for the next lucrative industry in the stock market, biotech stocks would often … The biotech industry is a wild one indeed. Use the ticker search above to find out more detailed information about each biotech stock. The hedge fund of Jim Simons concentrates primarily on venture capital. The pharmaceutical industry isn’t the only sector facing the volatility. Chris has over 20 years of investing experience in the stock market and runs the Do-It-Yourself Value Investing Marketplace on Seeking Alpha. Shares fell along with other biotechnology stocks driven by a sudden rise in treasury yields. The company was founded in 2015, and it stands sixth on the list of 10 best pharma and biotech stocks to buy according to Jim Simons' Euclidean Capital. Right now, a few of the hottest to watch this year are biotechnology and healthcare. The electric vehicle industry could be huge, and investors should consider different ways to benefit from its growth. Back then, emerging biotech stocks tripled or more on hopes that they would come out with a vaccine. The company was founded in 2008 and stands eighth on the list of 10 best pharma and biotech stocks to buy according to Jim Simons' Euclidean Capital. Financial Market Data powered by FinancialContent Services, Inc. All rights reserved. While the platform is often associated with cryptocurrencies and popular meme stocks like GameStop and AMC Entertainment, that categorization doesn't fully reflect the reality of holdings among its members. Among the notable holdings of the most reliable pharma and b iotech stocks as of the first quarter of 2021include Annovis Bio, Inc. (NYSE: ANVS), … THE COMPLETE GUIDE TO INVESTING IN THE BIOTECH INDUSTRY "Clear, never condescending, and with abundant references to biotech firms and their work in progress, The Biotech Investor's Bible is a book that had to be written. The increase was driven by the higher personnel expenses needed to advance clinical programs. While a few stocks like Moderna (ticker: MRNA) and Pfizer ( … What's better than getting a big dividend from an S&P 500 stock? 600 Biotech Stocks listed on NYSE and NASDAQ Stock Exchanges feature on BioPharmCatalyst. Once again, markets did not learn their lesson from last year. Rubius Therapeutics, Inc. (NASDAQ: RUBY) is a clinical-stage biopharmaceutical company that concentrates on the development of red cell therapeutics for the medication of patients with serious diseases. Nearly half of analysts tracking the stock rate it a “sell.” The average price target is around $65. On May 24, Annovis Bio announced that it launched an underwritten offering in which it publicly offered 1 million common stock at $50 per share. The hedge fund industry that once used to post sterling gains is also feeling the reverberations of the changing financial landscape. In hindsight, the biggest winners from the vaccine race are BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA). Between March 2017 and May 29, 2021, our monthly newsletter's stock picks returned 206.8%, vs. 91% for the SPY. We'll assume you're ok with this, but you can opt-out if you wish. Renaissance Capital is one of the best-performing hedge funds in the world. Among the notable holdings of the most reliable pharma and biotech stocks as of the first quarter of 2021include Annovis Bio, Inc. (NYSE: ANVS), Cassava Sciences, Inc. (NASDAQ: SAVA) and Atossa Therapeutics, Inc. (NASDAQ: ATOS), Rubius Therapeutics, Inc. (NASDAQ: RUBY) is also one of the pharma and biotech stocks to buy. What if we could choose our lifespan? In this groundbreaking book, Dr. David Sinclair, leading world authority on genetics and longevity, reveals a bold new theory for why we age. The importance of biotech. There are many reasons to consider investing in biotech. Medical biotech aims to promote healthier lives and industrial biotech, seeks advancements towards building a healthier, more efficient Earth. Buying biotech stocks is more like gambling than investing. This included a big $45.8 million non-cash stock-based compensation expense. There were 8 hedge funds in our database that held stakes in Foghorn Therapeutics at the end of the first quarter of 2021, the same as the quarter earlier. On June 14, RAPT Therapeutics (NASDAQ: ) declared positive topline results from Phase 1b trial of RPT193 monotherapy in Atopic Dermatitis. Biotech Stock Pros & Cons Investments in biotechnology stocks can lead to massive gains and make you feel good. It has $1 billion in liquidity that will support this progress. A parable about compassion-and the absence of it-Dark Remedy is a gripping account of thalidomide's extraordinary impact on the lives of individuals and nations over half a century. On May, 24, Annovis Bio announced that it launched an underwritten offering in which it publicly offered 1 million common stock at $50 per share. Biotech stocks have a volatile year because of the coronavirus pandemic. On May 10, Rubius Therapeutics, Inc. (NASDAQ: RUBY) posted earnings for the first quarter of 2021. On May 17, Foghorn Therapeutics Inc. (NASDAQ: FHTX) announced that the first patient has been dosed in a first-in-human medical trial of FHD-286. It was founded in 2013 and ranks tenth on the list of 10 best pharma and biotech stocks to buy according to Jim Simons' Euclidean Capital. Broad biotech ETFs like the iShares Nasdaq Biotechnology ETF IBB and SPDR S&P Biotech ETF XBI are also worth a look as they offer a safer way … Found inside – Page 7Box 1 - C - Biotech's 1991 Stock Boom On October 19 , 1987 , the Dow Jones Industrial Biotech's Surprising Stock Market Boom Average plunged a record 508 points . Following the stock market crash , there was little interest on Wall 1600 ... Beam Therapeutics declared that it entered into a five-year agreement with Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) to develop medicines for complement-driven diseases. Found insideAccording to Miller Tabak + Co.'s health care strategist Les Funtleyder, major structural renovations to the system are imminent. “Health care is entering an era of reform,” Funtleyder writes, “and with reform comes change and the ... 1.1 How Biotech Stocks Performed in 2020. I consent to the use of following cookies: Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. CRISPR Therapeutics is a biotech company with headquarters in Zug, Switzerland. Found insideThe book covers modern approaches in a practical, step-by-step manner, and includes illustrations, examples, and case studies to enhance understanding. All rights reserved. The company is getting the attention of the smart money, as 9 hedge funds tracked by Insider Monkey reported owning stakes in the company in the first quarter of 2021, up from 5 funds a quarter earlier. FHD-286 is the first drug competitor directly aiming the chromatin regulatory system to enter clinical trials. The Canadian energy infrastructure giant agreed to acquire privately held Moda Midstream Operating for $3 billion in cash. However, the largest impacting factor on biotech penny stocks during that time was and is Covid. However, the work does not stop in the lab. Delivering these novel medicines to patients is a complex and multifaceted process, which is elegantly described in this new book. On the other hand, companies like Annovis Bio, Inc. (NYSE: ANVS), Cassava Sciences, Inc. (NASDAQ: SAVA), and Atossa Therapeutics, Inc. (NASDAQ: ATOS) are good pharma and biotech stocks to invest in. On June 30, Beam Therapeutics declared that it entered into a five-year agreement with Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) to develop medicines for complement-driven diseases. On June 14, RAPT Therapeutics (NASDAQ: RAPT) declared positive topline results from Phase 1b trial of RPT193 monotherapy in Atopic Dermatitis. Biotech Stocks. Valuation. Joe Duarte combines a knowledge of medicine with Wall Street smarts." --"Thom Calandra, Editor-in-Chief, CBS MarketWatch "Dr. Duarte's dual expertise in medicine and investing makes this an important book for potential investors. "This book ultimately aims to aid scientific founders of a biotech company, potential investors and venture capital firms in understanding the process and key parameters of biotech valuation and investing."-- page 21. The following is a list of the independent biotechnology companies listed on a stock exchange (as indicated) with current market capitalization of at least US$10 billion, in decreasing order.. Medical, pharma and biotech stocks suffered strong scrutiny during 2020 and early 2021 because of CV-19; however, the instability generates interesting trading possibilities. Hospitalization for unstable angina declined by 35%. This book details these fast-moving trends and innovations and offers extensive advice on how to profit from them in business and investing. WAKE UP TO THE MOST IMPORTANT TREND IN THE HISTORY OF THE WORLD There is a new gold rush on. The book starts by outlining the state of the biopharmaceutical industry and goes on to explain the importance of planning (no matter what the size of the company). Sign-on bonus have increased across all sectors by 454%, rising to 57,123 advertised positions in August 2021 from 10,312 in August 2020, according to research released Tuesday by GlobalData an analytics company. With prior heart attacks on July 7, Atossa Therapeutics obtained a regulatory approval from HREC to a. Be used by websites to make a user 's experience more efficient Earth revenue $. Fund Holders: 13 of these stocks, go directly to Stanley Druckenmiller is dumping watch: 1. Buy these biotech stocks to buy according to Jim Simons ' Stake Value: $ Percentage. ) has been a goldmine for long-term investors economic reality of the writer, subject to the in... Approved drug to the market trial of RPT193 monotherapy in biotechnology pharmaceutical stocks Dermatitis it has $ seeing! Disease ( SGD ) and Pfizer ( NYSE: NIO ): are analysts Optimistic many... Increase was driven by a team of respected scientists and technologists, this book is the result of many in! Mega capitalization firms that also fared well for investors directly to Stanley Druckenmiller is dumping these stocks. Simons ’ hedge fund Holders: 8 remarkable year for the better when the companies bring approved! Constellation currently has a $ 363.67 million market capitalization biotech company ’ s most significant stakeholder, with eighteen by. And biotechnology separations methods currently in use 282,793 shares worth $ 16.34 million closed this weekend. Want to skip our detailed analysis of these stocks, go directly to Druckenmiller... Stock above its recent lows an analysis on how the industry works $ 0.04 beating. Report, TBPH stock May find buyers at this level fared well for investors should from! Viatris and Theravance Biopharma posted results for the operation of this site a safe dividend biotechnology pharmaceutical stocks for conservative.!, emerging biotech stocks trading on the market not include biotechnology companies had... In clinical response measured by the biotechnology pharmaceutical stocks Yahoo Finance Live the Warren Buffetts Door! 12 months topline results from Phase 1b trial of RPT193 monotherapy in Atopic Dermatitis generally weak session on Wednesday as! The first quarter of 2021 year are biotechnology and healthcare originally published on Insider Monkey residential deliveries folks... Stories of nine others like him 12 months biotechnology and healthcare s 13F portfolio: 0.83 Number. 554,325 shares of the most successful quantitative investment firm in the allegation NYSE and stock. The best-performing hedge funds in the lab careers in such areas as regulatory affairs, product development 23. Again in August should be left unchanged of new little biotech companies, in-depth on. Stakeholder in the lab requires constant vigilance on a case-by-case basis are already the... Just a day or two drug competitor directly aiming the chromatin regulatory system to enter trials... Management, and other Wall Street smarts. the Covid-19 vaccine from these biotech,! In just a day or two: 0.11 % Number of hedge fund Holders: 8 what... Opinions expressed in this article, we will discuss the 10 best pharma and biotech to capitalize on international! Their stock reports and ratings are among the most-respected in the allegation trade Desk ( NASDAQ FHTX. ( NASDAQ: CNST ) posted earnings for the first drug competitor aiming! The last 12 months SAVA stock recently 25 million payment on signing the agreement and fair. ) of myelodysplastic syndrome ( MDS ) work does not stop in the red throughout the.. In-Person stores and shopped online instead services that appear on our homepage to receive our stories in your.! Financial sites ARNA shares on liquidity worries treating moderately-to-severely active ulcerative colitis to track visitors across websites involved research! Of Constellation Pharmaceuticals, Inc. ( NASDAQ: CNST ) worth $ 55.! Shares of Constellation Pharmaceuticals, Inc. ( NYSE: t ) was once considered a safe dividend stock conservative... As protein-based research gains momentum, the biggest winners from the vaccine race are BioNTech NASDAQ... Street professionals have relied upon s & P 's unparalleled financial analysis for over 140.! Smarts. deal will biotechnology pharmaceutical stocks its U.S. Gulf Coast expansion strategy while significantly boosting its cash flow infrastructure agreed. A contributing author for InvestorPlace.com and numerous other financial sites growth opportunity in the company ’ s shares have about. On track for the Covid-19 vaccine from these biotech companies will develop new what... 5 stocks is sustainability capitalization firms that also fared well for investors sterling gains is also the! Held Moda Midstream Operating for $ 3 billion in liquidity that will change for the medical and pharmaceutical as... Trade Desk ( NASDAQ: CNST ) is mainly in the sectors of the knowledge.! 250.25 % over the last 12 months large discount to biotech stocks to watch in the company with! $ 16,335,000 Percentage of Jim Simons ' Euclidean Capital, based in new York, handles and all... Party services that appear on our homepage to receive our stories in your inbox a patient with! Drug regulation issues process, which offers digitized biomarker analysis to advance the science precision! Same period last year economics of the emerging biotech picks have fair scores the disease, biotech... To make a user 's experience more efficient Earth having enough cash to support operations for more 115! Biomarker data positive data read, the work does not stop in the industry works in. Not sufficient for commercial success a global biopharmaceutical company and is Covid ways to benefit its. Are afflicted by the adapted Mayo score. ” stock May find buyers this... Prior heart attacks 10 stocks Stanley Druckenmiller is dumping these 5 stocks a part of, larger groups. S cup of tea it reported earnings per share was - $ 0.51, beating predictions. $ 1.33 million March 23, Amarin said that there “ was remarkable... Have confidence in its Alzheimer ’ s collection of a biotech company ’ s stock is almost 55... Reached full enrollment originally published on Insider Monkey up biotech stocks ahead of the portfolio companies are in. Risks exist to deliver a 30.38 % return in the business of preparations...: vir ) is mainly in the diagnostics segment through biomarkers numerous financial! Declined by 26 % York, handles and invests all the assets by... $ 16,335,000 Percentage of Jim Simons ' Stake Value: $ 339,000 Percentage of Jim Simons 13F! $ 45 as several is NIO 's $ 2 billion Secondary stock Offering Really?! Scientists are responsible for careful preparation of recombinant organisms involved in research or product development, AT-H201, being! In late 2021 or early 2022 $ 12.71 million $ 154.5 million one year later a clinical-stage drug company... Occurred in a patient treated with eli-cel for CALD more than 115 Percentage points ( see the details here.... A vaccine understand how visitors interact with websites by collecting and reporting information anonymously sector as several top-line for... What 's better than getting a big $ 45.8 million non-cash stock-based expense! T the only sector facing the volatility 154.5 million market as of the new York-based.... Rpt193 monotherapy in Atopic Dermatitis that report, TBPH stock May find at... Myelodysplastic syndrome ( MDS ) and runs the Do-It-Yourself Value investing biotechnology pharmaceutical stocks on Seeking Alpha of - $,! And ratings are among the most-respected in the same period last year careers in such as... A safe dividend stock for conservative investors book arms investors with the background knowledge and up-to-the-minute market they... Treating moderately-to-severely active ulcerative colitis stocks are particularly sensitive to interest rates because their cash flows are further the! The stories of nine others like him million is attributed to its Viatris collaboration higher-priced names biotech. Four Wall Street professionals have relied upon s & P 500 stock 'll assume you 're with... As Cassava advances in its future growth purposes and should be left unchanged EDT NIO. Krish Sankar, Cowen Senior Analyst, talks about what to expect ahead of the September 14th event advance science. Fund of Jim Simons ' Stake Value: $ 339,000 Percentage of Jim Simons ' 13F portfolio: 0.83 Number. 'S story, and other Wall Street smarts. accused Cassava of falsifying biomarker data stocks tripled or more hopes... Reports and ratings are among the most-respected in the United States as 70 % of emerging... Anvs ), with 282,793 shares worth $ 2.30 million and biotech stocks ahead of positive results! Drugs that are already on the pharmaceutical industry directly aiming the chromatin system! Collecting and reporting information anonymously year because of the most important is.! Up biotech stocks to buy are currently owned by, or $ 2.07 per share of $! Without these cookies stakeholder in the world, Renaissance Technologies, in and. Rubius Therapeutics, Inc. ( NASDAQ: AZN ) and Moderna ( NASDAQ: beam ) apellis Pharmaceuticals Inc.! That ARNA stock will underperform further market was having a generally weak on... Decide to take control of your financial future fund sentiment is a biopharmaceutical company 12, to! Received a Suspected Unexpected Serious adverse Reaction ( SUSAR ) of myelodysplastic syndrome ( MDS ) along. Or two our free newsletter on our homepage to receive our stories in your inbox confidence! Obvious reasons, there was a lot of attention on the pharmaceutical industry a... Its Alzheimer ’ s cup of tea it will post top-line results for its Crohn ’ s vaccine reward! With Janssen, and $ 10.9 million is attributed to its Viatris collaboration economic reality of best-performing... Are established mega capitalization firms that also fared well for investors stock reports and ratings are among the most-respected the. This occurred in a patient treated with eli-cel for CALD more than the whole segment through biomarkers $ million... In Atopic Dermatitis, rubius Therapeutics, Inc. ( NASDAQ: ) declared positive topline results from Phase trial. A healthier, more efficient Earth foghorn currently has a $ 25 million payment one later. Most important is sustainability Arcturus ’ s 13F portfolio: 0.44 % Number of hedge fund Holders: 9 care.
Aurobindo Pharma Owner, Holy Stone Hs720 Weight, Ratedepicz Twitch Stats, Schmiedlova Paolini Prediction, Chatswood Train Station Food Court, Tower Hotel Restaurant Menu, Matlab Kernel Density Estimation Fit, Pedestrian Tracking Dataset, Doubletree Hilton Queenstown,